These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9595476)

  • 21. The effect of castration on endothelins, their receptors and endothelin converting enzyme in rat prostate.
    Takahashi W; Afiatpour P; Jr Foster HE; Ikeda K; Wada Y; Weiss RM; Latifpour J
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):166-76. PubMed ID: 12122504
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Renal cyclooxygenase and lipoxygenase products are altered in polycystic kidneys and by dietary soy protein and fish oil treatment in the Han:SPRD-Cy rat.
    Ibrahim NH; Jia Y; Devassy JG; Yamaguchi T; Aukema HM
    Mol Nutr Food Res; 2014 Apr; 58(4):768-81. PubMed ID: 24170691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study.
    Ogbron MR; Sareen S; Prychitko J; Buist R; Peeling J
    Am J Physiol; 1997 Jan; 272(1 Pt 2):F63-9. PubMed ID: 9039050
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Regulatory effect of experimental diabetes on the expression of endothelin receptor subtypes and their gene transcripts in the rat adrenal gland.
    Ikeda K; Wada Y; Sanematsu H; Foster HE; Shin D; Weiss RM; Latifpour J
    J Endocrinol; 2001 Jan; 168(1):163-75. PubMed ID: 11139780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Renal expression of FGF23 and peripheral resistance to elevated FGF23 in rodent models of polycystic kidney disease.
    Spichtig D; Zhang H; Mohebbi N; Pavik I; Petzold K; Stange G; Saleh L; Edenhofer I; Segerer S; Biber J; Jaeger P; Serra AL; Wagner CA
    Kidney Int; 2014 Jun; 85(6):1340-50. PubMed ID: 24402093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endothelin binding to NG108-15 cells: evidence for conventional ETA and ETB receptor subtypes and super-high affinity binding components.
    Angelova K; Ergul A; Narayan P; Puett D
    Cell Mol Biol (Noisy-le-grand); 1996 Dec; 42(8):1243-57. PubMed ID: 8997527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Paracrine renal endothelin system in rats with liver cirrhosis.
    Hocher B; Zart R; Diekmann F; Rohmeiss P; Distler A; Neumayer HH; Bauer C; Gross P
    Br J Pharmacol; 1996 May; 118(2):220-7. PubMed ID: 8735618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal remodelling in dietary protein modified rat polycystic kidney disease.
    Bankovic-Calic N; Eddy A; Sareen S; Ogborn MR
    Pediatr Nephrol; 1999 Sep; 13(7):567-70. PubMed ID: 10460502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of endothelin-1, ETA and ETB receptors, and ECE and distribution of endothelin-1 in failing rat heart.
    Kobayashi T; Miyauchi T; Sakai S; Kobayashi M; Yamaguchi I; Goto K; Sugishita Y
    Am J Physiol; 1999 Apr; 276(4):H1197-206. PubMed ID: 10199843
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of chronic cold exposure on the endothelin system.
    Chen GF; Sun Z
    J Appl Physiol (1985); 2006 May; 100(5):1719-26. PubMed ID: 16384835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of Sodium-Glucose Cotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease.
    Rodriguez D; Kapoor S; Edenhofer I; Segerer S; Riwanto M; Kipar A; Yang M; Mei C; Wüthrich RP
    Kidney Blood Press Res; 2015; 40(6):638-47. PubMed ID: 26698317
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).
    Wahl PR; Serra AL; Le Hir M; Molle KD; Hall MN; Wüthrich RP
    Nephrol Dial Transplant; 2006 Mar; 21(3):598-604. PubMed ID: 16221708
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Divergent expression of EtA and EtB receptors in response to cyclosporine in mesangial cells.
    Takeda M; Iwasaki S; Hellings SE; Yoshida H; Homma T; Kon V
    Am J Pathol; 1994 Mar; 144(3):473-9. PubMed ID: 8129032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Caspase inhibition reduces tubular apoptosis and proliferation and slows disease progression in polycystic kidney disease.
    Tao Y; Kim J; Faubel S; Wu JC; Falk SA; Schrier RW; Edelstein CL
    Proc Natl Acad Sci U S A; 2005 May; 102(19):6954-9. PubMed ID: 15863619
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Function and expression of endothelin receptor subtypes in the kidneys of spontaneously hypertensive rats.
    Hocher B; Rohmeiss P; Zart R; Diekmann F; Vogt V; Metz D; Fakhury M; Gretz N; Bauer C; Koppenhagen K; Neumayer HH; Distler A
    Cardiovasc Res; 1996 Apr; 31(4):499-510. PubMed ID: 8689641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mycophenolate mofetil versus Rapamycin in Han: SPRD rats with Polycystic Kidney Disease.
    Zhang T; Wang L; Xiong X; Mao Z; Wang L; Mei C
    Biol Res; 2009; 42(4):437-44. PubMed ID: 20140299
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The expression and activity of renal nitric oxide synthase and circulating nitric oxide in polycystic kidney disease rats.
    Wang D; Braendstrup O; Larsen S; Horn T; Strandgaard S
    APMIS; 2004 Jun; 112(6):358-68. PubMed ID: 15511273
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification, characterization, and biological activity of endothelin receptors in human ovary.
    Mancina R; Barni T; Calogero AE; Filippi S; Amerini S; Peri A; Susini T; Vannelli GB; Burrello N; Forti G; Maggi M
    J Clin Endocrinol Metab; 1997 Dec; 82(12):4122-9. PubMed ID: 9398725
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long-term rapamycin therapy in the Han:SPRD rat model of polycystic kidney disease (PKD).
    Zafar I; Belibi FA; He Z; Edelstein CL
    Nephrol Dial Transplant; 2009 Aug; 24(8):2349-53. PubMed ID: 19321761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor κB-induced inflammation.
    Wu M; Gu J; Mei S; Xu D; Jing Y; Yao Q; Chen M; Yang M; Chen S; Yang B; Qi N; Hu H; Wüthrich RP; Mei C
    Nephrol Dial Transplant; 2016 Nov; 31(11):1826-1834. PubMed ID: 27190325
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.